Bio-Techne Corp at JPMorgan Healthcare Conference Transcript
Awesome. Good morning, everyone. This is Rachel Vatnsdal from the Life Science Tools and Diagnostics team. Welcome to the Bio-Techne presentation. I have the management team up on stage with me. So this will be a 40-minute session, roughly 20, 25 minutes of presentation, followed by Q&A. If any of you in the room do have questions, feel free to either submit the questions via the portal or you can ping me directly.
And with that, I will pass it off to Kim for the presentation.
Thank you, Rachel. Thank you, JPMorgan, for hosting the company every year at this fantastic conference. Let me draw your attention to the safe harbor statement. You can find it on biotechne.com. And with that, let me start with introducing myself.
My name is Kim Kelderman, I'm going to be -- I am President and I'm going to be CEO of Bio-Techne on February 1. I want to thank the Board of Directors of Bio-Techne for the confidence they
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
